Zimmer Biomet Holdings Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.Zimmer Biomet Holdings Inc. (ZBH) shares rose 1.09% to $89.65 on Thursday, snapping a four-day losing streak despite a broader market decline. The S&P 500 and Dow Jones fell 1.21% and 0.97%, respectively. ZBH underperformed competitors like Johnson & Johnson, Medtronic, and Stryker, which all posted gains. Trading volume was below the 50-day average, and the stock remains 17.21% below its 52-week high.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zimmer Biomet Holdings Inc. (ZBH) rose 1.09% to $89.65 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.
The stock's rise snapped a four-day losing streak.
Zimmer Biomet Holdings Inc. closed 17.21% below its 52-week high of $108.29, which the company achieved on August 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.42% to $259.27, Medtronic PLC (MDT) rose 0.15% to $82.01, and Stryker Corp. (SYK) rose 3.15% to $318.97.
Trading volume (1.6 M) remained 675,380 below its 50-day average volume of 2.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-23-26 1709ET